Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 19, 2020
Envision Pharma Group has announced the acquisition of Two Labs.
read more
Monday, September 07, 2020
Envirotainer announced they are expanding their network of stations by adding Beijing (PEK), China, to the list of e-technology network stations.
read more
Envirotainer has announced that Debbie Ng has joined Envirotainer as the new Head of Operations APAC at its new operation center in Singapore. This is part of Envirotainer’s strategy to help strengthen its support in the region.
read more
Wednesday, October 07, 2015
Envirotainer now launches a new service – an Availability Guarantee that ensures availability of RKN e1 containers at all European locations for all shippers. This unique offering in the market will support the pharmaceutical industry in supplying ...
read more
Tuesday, February 21, 2017
Envigo has announced that it has developed and validated a robust analytical method to evaluate the potential effects on thyroid hormone levels in rat F1 offspring.
read more
Wednesday, March 30, 2016
Envigo has been granted full accreditation for its Horst, Netherlands site from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council. AAALAC informed Envigo that that the criteria for achieving ...
read more
Envigo is investing in an expansion of its research model surgical facility at its Livermore, California site in response to increased market demand from West Coast biopharmaceutical customers.
read more
Sunday, February 26, 2017
Envigo has developed and validated a robust analytical method to evaluate the potential effects on thyroid hormone levels in rat F1 offspring. It is now possible for Envigo to successfully determine levels of T3 (triiodothyronine) and T4 (thyroxine) ...
read more
Envigo will launch the “R2G2” mouse at the American Association for Cancer Research (AACR) annual meeting in Washington DC, April 1-5, 2017. The R2G2, a Rag2/IL2RG double knockout model, was created by backcrossing the common gamma chain gene ...
read more
Envigo announced the launch of PATHWAY – an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials.
read more
Monday, November 07, 2016
Envigo has announced the launch of an integrated program of in vitro technologies that help predict the likelihood of compounds causing drug induced livery injury (DILI) – one of the major causes of drugs being withdrawn from the market.
read more
Monday, September 26, 2016
Envigo has announced the launch of a dedicated Science and Technology Advisory Group (STAG) to drive forward emerging areas of research and to collaborate with customers to develop new technologies.
read more
Tuesday, November 22, 2016
Envigo has announced that its contract research facilities in Barcelona, Spain have been granted full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council.
read more
Wednesday, March 15, 2017
Envigo announced that it will develop and internally validate five to seven ion channel In vitro tests for measuring cardiac risk potential – ahead of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) recommendations expected at the end of this ...
read more
Thursday, September 30, 2021
Envigo RMS Holding Corp. (or Envigo) announces a collaboration with Biocytogen, a global biotech company that drives the research and development of new drugs with innovative technologies. The two companies are committed to supporting research ...
read more